Endurant Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-11,254
| Closed | -$787K | – | 31 |
|
|
2023
Q3 | $787K | Buy |
+11,254
| New | +$787K | 0.71% | 33 |
|
|
2023
Q1 | – | Sell |
-11,264
| Closed | -$869K | – | 53 |
|
|
2022
Q4 | $869K | Buy |
+11,264
| New | +$869K | 0.35% | 40 |
|
|
2022
Q3 | – | Sell |
-15,246
| Closed | -$584K | – | 52 |
|
|
2022
Q2 | $584K | Sell |
15,246
-85,053
| -85% | -$3.26M | 0.2% | 42 |
|
|
2022
Q1 | $4.15M | Buy |
100,299
+44,670
| +80% | +$1.85M | 1.09% | 25 |
|
|
2021
Q4 | $2.1M | Buy |
55,629
+3,581
| +7% | +$135K | 0.51% | 37 |
|
|
2021
Q3 | $1.72M | Buy |
+52,048
| New | +$1.72M | 0.39% | 41 |
|
|
2020
Q2 | – | Sell |
-12,367
| Closed | -$728K | – | 59 |
|
|
2020
Q1 | $728K | Buy |
12,367
+1,216
| +11% | +$71.6K | 0.33% | 39 |
|
|
2019
Q4 | $1.15M | Buy |
+11,151
| New | +$1.15M | 0.36% | 41 |
|
|
2019
Q2 | – | Sell |
-52,268
| Closed | -$744K | – | 55 |
|
|
2019
Q1 | $744K | Sell |
52,268
-156,927
| -75% | -$2.23M | 0.29% | 50 |
|
|
2018
Q4 | $590K | Buy |
209,195
+114,010
| +120% | +$322K | 0.31% | 43 |
|
|
2018
Q3 | $328K | Buy |
+95,185
| New | +$328K | 0.15% | 71 |
|